HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Clerico, A. Articles by Emdin, M. Search for Related Content PubMed PubMed Citation Articles by Clerico, A. Articles by Emdin, M. Related Collections Laboratory Management General Clinical Chemistry Proteomics and Protein Markers Lipids, Lipoproteins, and Cardiovascular Risk Factors

Clinical Relevance of Biological Variation of B-Type Natriuretic Peptide

Consiglio Nazionale delle Ricerche, Institute of Clinical Physiology, Pisa, Italy

^aAddress correspondence to this author at: Laboratory of Cardiovascular Endocrinology and Cell Biology, CNR Institute of Clinical Physiology, Via Trieste 41, 56126 Pisa, Italy. Fax 39-0585-493601; e-mail clerico@ifc.cnr.it.

The first 20% of the full text of this article appears below.

To the Editor:

The cardiac natriuretic hormones (CNHs), atrial (ANP) and B-type natriuretic peptide (BNP), are peptides produced and secreted by the atrial and ventricular cardiomyocytes, respectively. ANP and BNP share potent diuretic, natriuretic, and vascular smooth-muscle-relaxing effects and interact with the hormonal and nervous systems (1)(2)(3). Stimulation by hemodynamic overload, as well as by several neuroendocrine (including -adrenergic agonists, angiotensin II, endothelins, and vasopressin) and immunologic agents and by growth factors, modulates the production of CNHs by the human heart (1)(2). CNHs and their respective counter-regulatory neurohormonal systems (including the adrenergic, endothelin, and renin-angiotensin-aldosterone systems) form a physiologic negative feedback mechanism that regulates cardiac output by controlling blood pressure and heart rate as well as by fluid and electrolyte homeostasis (1)(2).

The clinical relevance of measurement of BNP and its related peptides as diagnostic tools and prognostic markers in patients with cardiovascular diseases has been confirmed recently (2)(3). To achieve correct interpretation of serial test results that are collected for follow-up or for tailored treatment . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				A. H.B. Wu, Q. A. Lu, J. Todd, J. Moecks, and F. Wians Short- and Long-Term Biological Variation in Cardiac Troponin I Measured with a High-Sensitivity Assay: Implications for Clinical Practice Clin. Chem., January 1, 2009; 55(1): 52 - 58. [Abstract] [Full Text] [PDF]

				A M. Richards Variability of NT-proBNP levels in heart failure: implications for clinical application Heart, August 1, 2007; 93(8): 899 - 900. [Abstract] [Full Text] [PDF]

				M. R. Fokkema, Z. Herrmann, F. A.J. Muskiet, and J. Moecks Reference change values for brain natriuretic peptides revisited. Clin. Chem., August 1, 2006; 52(8): 1602 - 1603. [Full Text] [PDF]